API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.fiercepharma.com/pharma/mercks-key-pah-approval-tap-johnson-johnson-wins-nod-pah-combo-tablet
https://www.prnewswire.com/news-releases/us-fda-approves-opsynvi-macitentan-and-tadalafil-as-the-first-and-only-once-daily-single-tablet-combination-therapy-for-patients-with-pulmonary-arterial-hypertension-pah-302097530.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218232
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/today-world-issues-voluntary-nationwide-recall-all-lots-sustain-and-schwinnng-brand-dietary
https://www.globenewswire.com/news-release/2023/06/26/2694136/0/en/Janssen-Submits-Marketing-Authorisation-Application-to-the-European-Medicines-Agency-EMA-Seeking-Approval-of-Single-Tablet-Combination-Therapy-STCT-of-Macitentan-and-Tadalafil-for-.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212515
https://www.prnewswire.com/news-releases/janssen-submits-new-drug-application-to-us-fda-seeking-approval-of-investigational-single-tablet-combination-therapy-of-macitentan-and-tadalafil-for-treatment-of-patients-with-pulmonary-arterial-hypertension-pah-301834852.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2023-46659.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf
https://www.fiercepharma.com/pharma/acc23-jjs-combo-pill-opsumit-plus-tadalafil-improves-blood-flow-pah-patients
https://www.prnewswire.com/news-releases/late-breaking-phase-3-a-due-data-show-investigational-single-tablet-combination-therapy-of-macitentan-and-tadalafil-significantly-improves-pulmonary-hemodynamics-versus-monotherapy-in-patients-with-pulmonary-arterial-hypertension--301762855.html
https://www.pharmacompass.com/pdf/news/volt-candy-issues-voluntary-nationwide-recall-of-primezen-black-6000-capsules-due-to-presence-of-sildenafil-and-tadalafil-4249.pdf
https://www.prnewswire.com/news-releases/cmp-pharma-inc-announces-that-tadliq-the-first-and-only-fda-approved-liquid-suspension-of-tadalafil-is-now-available-301656771.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216932
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/proper-trade-llcmy-stellar-lifestyle-issues-voluntary-nationwide-recall-wonder-pill-capsules-due
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210608
https://www.rttnews.com/3297551/mks-enterprise-recalls-dose-vital-vip-vital-honey.aspx
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mks-enterprise-llc-voluntary-recalls-dose-vital-vip-vital-honey-due-presence-undeclared-tadalafil
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/loud-muscle-science-llc-issues-voluntary-recall-launch-sequence-capsules-due-presence-undeclared
https://www.statnews.com/2022/06/15/erectile-dysfunction-drug-may-help-men-with-diabetic-heart-damage-not-women/
https://www.expresspharma.in/us-fda-presses-pause-on-trial-for-otc-version-of-cialis/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-02-2022-1646291076.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/positive-health-issues-voluntary-nationwide-recall-rise-red-edition-capsules-due-presence-undeclared
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/celebrate-today-issues-voluntary-nationwide-recall-one-lot-red-mammoth-due-presence-undeclared
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/abc-sales-1-inc-issues-voluntary-nationwide-recall-mac-daddy-red-and-mac-daddy-purple-capsules-due
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/your-favorite-shop-issues-voluntary-nationwide-recall-red-pill-capsules-due-presence-undeclared
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/junp-llc-issues-voluntary-nationwide-recall-megman-performance-booster-capsules-due-presence
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/esupplementsales-llc-issues-nationwide-recall-one-lot-hard-dawn-due-presence-undeclared-tadalafil
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-17-2021-1637135168.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215556
https://www.globenewswire.com/news-release/2021/09/29/2305793/0/en/IntelGenx-and-Aquestive-Therapeutics-Partner-with-Leading-Men-s-Health-Company-to-Market-Tadalafil-Oral-Films-in-the-U-S.html
https://www.pharmacompass.com/pdf/news/yamtun7-issues-voluntary-nationwide-recall-of-poseidon-platinum-3500-1620795419.pdf
https://ecipharma.com/2021/05/10/eci-pharmaceuticals-llc-signs-agreement-to-be-exclusive-u-s-distributor-of-generic-cialis/
https://www.pharmacompass.com/pdf/news/ns-ny-distributor-inc-issues-voluntary-nationwide-recall-of-premium-orgazen-7000-1618506818.pdf
https://www.pharmacompass.com/pdf/news/adamssecretco-issues-voluntary-nationwide-recall-of-adams-secret-extra-strength-1613545998.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-erectile-dysfunction-treatment/articleshow/80040795.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213496
https://www.businesswire.com/news/home/20200829005001/en/TRITON-Phase-3b-Study-Results-Presented-European#:~:text=In%20the%20TRITON%20trial%2C%20both,difference%20observed%20between%20both%20groups.
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/natural-remedy-store-issues-voluntary-worldwide-recall-active-male-due-presence-undeclared-tadalafil
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-5-2020-1580878802.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208824
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207290
https://www.pharmacompass.com/pdf/news/fitoterapia-usa-inc-issues-voluntary-nationwide-recall-of-mero-macho-artificial-passion-fruit-flavored-vitamin-c-liquid-supplement-1568701921.pdf
https://finance.yahoo.com/news/eli-lilly-tops-profit-estimates-124744250.html
https://www.fiercepharma.com/pharma/xofluza-hand-roche-offloads-tamiflu-u-s-otc-switch-rights-to-sanofi
https://www.fiercepharma.com/pharma/sanofi-eisai-join-eli-lilly-s-scotus-bid-to-protect-cialis-patent-bph?utm_source=internal&utm_medium=rss
https://www.fiercepharma.com/pharma/eli-lilly-throws-scotus-hail-mary-cialis-patent-infringement-fight
https://www.financialexpress.com/industry/dr-reddys-net-profit-up-44-per-cent-in-q4/1581719/
https://www.fiercebiotech.com/research/sheep-study-shows-cialis-might-reverse-heart-failure